User profiles for Paul D Robinson
Paul D. RobinsonConjoint Professor & Snr Staff Specialist, Respiratory&Sleep Dept, Queensland Children's … Verified email at uq.edu.au Cited by 6868 |
Consensus statement for inert gas washout measurement using multiple-and single-breath tests
Inert gas washout tests, performed using the single- or multiple-breath washout technique,
were first described over 60 years ago. As measures of ventilation distribution inhomogeneity, …
were first described over 60 years ago. As measures of ventilation distribution inhomogeneity, …
Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life
N Sigurs, F Aljassim, B Kjellman, PD Robinson… - Thorax, 2010 - thorax.bmj.com
Background An increased prevalence of asthma/recurrent wheeze (RW), clinical allergy
and allergic sensitisation up to age 13 years has previously been reported in subjects …
and allergic sensitisation up to age 13 years has previously been reported in subjects …
Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease
…, HM Polenakovik, PD Robinson… - Clinical infectious …, 2023 - academic.oup.com
Background Nontuberculous Mycobacterium infections, particularly Mycobacterium abscessus,
are increasingly common among patients with cystic fibrosis and chronic bronchiectatic …
are increasingly common among patients with cystic fibrosis and chronic bronchiectatic …
Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled …
…, CE Milla, PD Robinson, D Waltz… - The lancet Respiratory …, 2017 - thelancet.com
Background Lumacaftor and ivacaftor combination treatment showed efficacy in patients
aged 12 years or older with cystic fibrosis homozygous for F508del-cystic fibrosis …
aged 12 years or older with cystic fibrosis homozygous for F508del-cystic fibrosis …
The re-emerging burden of rickets: a decade of experience from Sydney
Aim: To define the demographics and clinical characteristics of cases presenting with
nutritional rickets to paediatric centres in Sydney, Australia. Methods: Retrospective descriptive …
nutritional rickets to paediatric centres in Sydney, Australia. Methods: Retrospective descriptive …
Inert gas washout: theoretical background and clinical utility in respiratory disease
PD Robinson, MD Goldman, PM Gustafsson - Respiration, 2009 - karger.com
Inert gas washout was first described more than 60 years ago and 2 principal tests have been
developed from it: the single breath and multiple breath washout (MBW) techniques. The …
developed from it: the single breath and multiple breath washout (MBW) techniques. The …
[HTML][HTML] Clinical significance and applications of oscillometry
…, BW Oppenheimer, PD Robinson… - European respiratory …, 2022 - Eur Respiratory Soc
Recently, “Technical standards for respiratory oscillometry” was published, which reviewed
the physiological basis of oscillometric measures and detailed the technical factors related to …
the physiological basis of oscillometric measures and detailed the technical factors related to …
An official American Thoracic Society workshop report: optimal lung function tests for monitoring cystic fibrosis, bronchopulmonary dysplasia, and recurrent wheezing …
…, S Ranganathan, CL Ren, PD Robinson… - Annals of the …, 2013 - atsjournals.org
Although pulmonary function testing plays a key role in the diagnosis and management of
chronic pulmonary conditions in children under 6 years of age, objective physiologic …
chronic pulmonary conditions in children under 6 years of age, objective physiologic …
Effects of load carriage on heart rate, blood pressure and energy expenditure in children
Y Hong, JX Li, ASK Wong, PD Robinson - Ergonomics, 2000 - Taylor & Francis
Fifteen male primary school children, aged 10 years, were selected to carry school bags of
10, 15 and 20% of their own body weights, where 0% body weight was used as a control. …
10, 15 and 20% of their own body weights, where 0% body weight was used as a control. …
Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function …
Rationale: The triple-combination regimen elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA)
was shown to be safe and efficacious in children aged 6 through 11 years with cystic fibrosis …
was shown to be safe and efficacious in children aged 6 through 11 years with cystic fibrosis …